Skip to main content
Contact Us
Subscribe
E-Edition
52°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Entertainment
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about GILD
Recent news which mentions GILD
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Gilead's CAR-T Yescarta Shows 78% Complete Response Rate In First-Line Lymphoma Patients
December 14, 2021
Tickers
GILD
Tags
GILD
Health Care
lymphoma
From
Benzinga
Gilead's Kite Unveils More Data On Yescarta In Second-Line Lymphoma Patients
December 13, 2021
Tickers
GILD
Tags
News
Biotech
Phase 3 Trial
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
Tickers
ABBV
ALL
ALSN
AMGN
Tags
Initiation
WRB
Analyst Ratings
From
Benzinga
Why Arcus Biosciences Stock Vaulted Higher in November
December 09, 2021
Tickers
GILD
RCUS
Tags
RCUS
Recent Press Releases
GILD
From
Motley Fool
Is Gilead Sciences Stock a Buy Now?
December 07, 2021
Tickers
GILD
MRK
NRXP
PFE
Tags
NRXP
GILD
PFE
From
Motley Fool
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
Tickers
ACAD
APTX
AZN
BLU
Tags
News
INFI
General
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
December 06, 2021
Tickers
AAL
AAPL
ACEL
AMGN
Tags
ZS
NVRO
WBX
From
Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
Tickers
ABBV
ADCT
AGIO
ALNY
Tags
MGTX
DTIL
AGIO
From
Benzinga
Gilead Recalls Two Lots Of Remdesivir Due To Presence Of Glass Particulates
December 06, 2021
Tickers
GILD
Tags
Health Care
FDA
GILD
From
Benzinga
December SPAC Merger Calendar: Upcoming Votes, Stocks To Watch
December 05, 2021
Tickers
AAL
ADF
ATHN
AXP
Tags
GIG
ADF
AAL
From
Benzinga
Got $1,000? Check Out These 3 Top Biotech Stocks
December 03, 2021
Tickers
BEAM
GILD
VRTX
Tags
Market News
BEAM
VRTX
From
Motley Fool
3 Reasons Pfizer Stock Will Crush the Broader Market in 2022
December 01, 2021
Tickers
ABBV
BNTX
GILD
LLY
Tags
PFE
GILD
LLY
From
Motley Fool
FDA advisers to vote Tuesday on Merck’s COVID-19 pill even as interest has waned
November 30, 2021
Tickers
GILD
GSK
LLY
MRK
Tags
VIR
GSK
LLY
From
MarketWatch
Why NRx Pharmaceuticals Stock Soared Today
November 29, 2021
Tickers
GILD
NRXP
Tags
Market News
NRXP
GILD
From
Motley Fool
Why Are NRx Pharma's Shares Soaring Premarket?
November 29, 2021
Tickers
GILD
NRXP
Tags
General
Trading Ideas
News
From
Benzinga
3 Dividend Stocks That Are Dirt Cheap Right Now
November 25, 2021
Tickers
GILD
MSBI
WU
Tags
GILD
Recent Press Releases
MSBI
From
Motley Fool
A Look Into Gilead Sciences Debt
November 24, 2021
Tickers
GILD
Tags
Benzinga
Market News
News
From
Benzinga
Gilead, Merck Stop Enrollment In Mid-Stage HIV Combination Therapy Trial
November 24, 2021
Tickers
GILD
MRK
Tags
Phase 2 Trial
Briefs
Market News
From
Benzinga
Gilead's Trodelvy Approved In Europe For Aggressive Form Of Breast Cancer
November 23, 2021
Tickers
GILD
Tags
European Medicines Agency
Market News
General
From
Benzinga
The Daily Biotech Pulse: Arrowhead Out-Licenses NASH Drug, Tonix Touts COVID-19 Treatment Data, Aadi Jumps On FDA Nod For Rare Tumor Drug
November 23, 2021
Tickers
AADI
ABEO
AMYT
APLT
Tags
SYBX
News
General
From
Benzinga
1 Cancer Stock on Buyout Watch in 2022
November 21, 2021
Tickers
AMGN
AZN
BIIB
BMY
Tags
NVS
BIIB
Recent Press Releases
From
Motley Fool
Better Buy: Vertex Pharmaceuticals vs. CRISPR
November 20, 2021
Tickers
BLUE
CRSP
GILD
VRTX
Tags
GILD
BLUE
CRSP
From
Motley Fool
Is Merck Stock a Buy?
November 20, 2021
Tickers
GILD
MRK
REGN
XLRN
Tags
GILD
MRK
XLRN
From
Motley Fool
Gilead Files US Application For Bulevirtide In Severe Form Of Viral Hepatitis
November 19, 2021
Tickers
GILD
Tags
GILD
Health Care
Phase 3 Trial
From
Benzinga
Why Are Arcus Biosciences Shares Trading Higher Today?
November 18, 2021
Tickers
GILD
RCUS
Tags
Contracts
why it's moving
Health Care
From
Benzinga
Why Arcus Biosciences Stock Is On Fire Today
November 18, 2021
Tickers
GILD
RCUS
Tags
Market News
GILD
RCUS
From
Motley Fool
2 High-Yield Dividend Stocks That Can Safeguard Your Portfolio Against a Market Crash
November 15, 2021
Tickers
ABBV
GILD
Tags
GILD
Recent Press Releases
Market News
From
Motley Fool
On Target: This Company Says It Delivers Drugs Exactly How You Need Them
November 15, 2021
Tickers
GILD
MTNB
Tags
Matinas BioPharma Holdings
Penny Stocks
Benzinga
From
Benzinga
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
November 11, 2021
Tickers
APTO
APYX
BIIB
BLFS
Tags
ELDN
VAXX
APYX
From
Benzinga
Better COVID Stock: Merck vs. Pfizer
November 09, 2021
Tickers
GILD
MRK
PFE
REGN
Tags
Market News
PFE
GILD
From
Motley Fool
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.